Novel melatonin-based treatments for major depression.

Novel melatonin-based treatments for major depression.

Bibliografske podrobnosti
Main Authors:	Barbui, C, Cipriani, A
Format:	Journal article
Jezik:	English
Izdano:	2012

Podobne knjige/članki

Venlafaxine for major depression.
od: Cipriani, A, et al.
Izdano: (2007)

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials.
od: Barbui, C, et al.
Izdano: (2008)

Depression in adults: drug and physical treatments.
od: Cipriani, A, et al.
Izdano: (2011)

Depression in adults: drug and physical treatments.
od: Barbui, C, et al.
Izdano: (2007)

Long-term treatment of depression with antidepressants: a systematic narrative review.
od: Furukawa, T, et al.
Izdano: (2007)

Role of melatonin in the treatment of depression
od: O. V. Kotova
Izdano: (2011-06-01)

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
od: Watanabe, N, et al.
Izdano: (2008)

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.
od: Nakagawa, A, et al.
Izdano: (2008)

Suicide, depression, and antidepressants.
od: Cipriani, A, et al.
Izdano: (2005)

What are evidence-based treatment recommendations?
od: Barbui, C, et al.
Izdano: (2011)

Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis.
od: Omori, I, et al.
Izdano: (2009)

Depressive disorder needs an evidence base commensurate with its public health importance.
od: Geddes, J, et al.
Izdano: (2007)

Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.
od: Cipriani, A, et al.
Izdano: (2007)

First line treatments post-cipriani Multiple treatments meta-analysis of antidepressants for major depression: strengths and weakness?
od: Cipriani, A
Izdano: (2010)

Suicide, depression, and antidepressants - Patients and clinicians need to balance benefits and harms
od: Cipriani, A, et al.
Izdano: (2005)

Melatonin is a biomarker of circadian dysregulation and is correlated with major depression and fibromyalgia symptom severity
od: Caumo W, et al.
Izdano: (2019-01-01)

Fluoxetine and amitriptyline: First-line treatments or reference compounds?
od: Barbui, C, et al.
Izdano: (2004)

Comparing Effects of Melatonin versus Trazodone on Sleep Quality in Major Depressed Patients Receiving Sertraline
od: Zahra Mirsepassi, et al.
Izdano: (2018-02-01)

Antidepressants in unipolar major depression: what we need to know
od: Barber, S, et al.
Izdano: (2016)

Experience with sustained-release melatonin for the treatment of sleep disorders in depression
od: Svetlana Vladimirovna Prokhorova, et al.
Izdano: (2015-10-01)

Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
od: Cipriani, A, et al.
Izdano: (2008)

Duloxetine versus other anti-depressive agents for depression.
od: Cipriani, A, et al.
Izdano: (2012)

Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
od: Xue-Qin Wang, et al.
Izdano: (2021-11-01)

A Novel Neuromodulation Strategy For The Treatment Of Major Depressive Disorder?
od: Kun Wei, et al.
Izdano: (2025-01-01)

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
od: Cipriani, A, et al.
Izdano: (2009)

Efficacy and tolerability of pharmacological treatments for personality disorders: A meta-analysis
od: Nose, M, et al.
Izdano: (2005)

Fluvoxamine versus other anti-depressive agents for depression.
od: Omori, I, et al.
Izdano: (2010)

Citalopram versus other anti-depressive agents for depression.
od: Cipriani, A, et al.
Izdano: (2012)

Morning and nocturnal serum melatonin rhythm levels in patients with major depressive disorder: an analytical cross-sectional study
od: Shahnaz Khaleghipour, et al.

Fluoxetine versus other types of pharmacotherapy for depression
od: Magni, L, et al.
Izdano: (2013)

Mirtazapine versus other antidepressive agents for depression.
od: Watanabe, N, et al.
Izdano: (2011)

Tryptophan and depression.
od: Barbui, C, et al.
Izdano: (1997)

Paroxetine versus other anti-depressive agents for depression
od: Purgato, M, et al.
Izdano: (2014)

National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative survey based analysis
od: Luo, Y, et al.
Izdano: (2020)

What is a multiple treatments meta-analysis?
od: Cipriani, A, et al.
Izdano: (2012)

Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis.
od: Barbui, C, et al.
Izdano: (2011)

Targeting the ferroptosis crosstalk: novel alternative strategies for the treatment of major depressive disorder
od: Luyao Wang, et al.
Izdano: (2023-10-01)

Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders
od: Miguel Pérez de la Mora, et al.
Izdano: (2022-06-01)

Escitalopram versus other antidepressive agents for depression.
od: Cipriani, A, et al.
Izdano: (2009)

Major depression disorder - etiology and treatment
od: Paulina Czuchryta, et al.
Izdano: (2023-06-01)